Aastrom Biosciences initiates new product program for treatment of bone related diseases.
Using the system, the production of bone-forming cells will begin with a small sample of cells, taken from a patient or donor. The product, designated the OC-I Therapy Kit, will be used to expand the small sample into a large quantity of the therapeutic bone-forming cells, Aastrom says. The new cells will then be infused into the patient, where they are to migrate to the bone areas, with the targeted result being the formation of new bone.
Contact: Todd Simpson - (734) 930-5777
|Printer friendly Cite/link Email Feedback|
|Comment:||Aastrom Biosciences initiates new product program for treatment of bone related diseases.|
|Date:||Apr 28, 2000|
|Previous Article:||Eon Labs, Mylan Pharmaceuticals enter agreement to co-promote generic cyclosporine softgel capsules to hospitals.|
|Next Article:||ASTS creating National Registry of all living donor liver transplant procedures to help assess risk.|